Seroprevalence of Chikungunya Virus after Its Emergence in Brazil
- PMID: 29553317
- PMCID: PMC5875253
- DOI: 10.3201/eid2404.171370
Seroprevalence of Chikungunya Virus after Its Emergence in Brazil
Abstract
Chikungunya has had a substantial impact on public health because of the magnitude of its epidemics and its highly debilitating symptoms. We estimated the seroprevalence, proportion of symptomatic cases, and proportion of chronic form of disease after introduction of chikungunya virus (CHIKV) in 2 cities in Brazil. We conducted the population-based study through household interviews and serologic surveys during October-December 2015. In Feira de Santana, we conducted a serologic survey of 385 persons; 57.1% were CHIKV-positive. Among them, 32.7% reported symptoms, and 68.1% contracted chronic chikungunya disease. A similar survey in Riachão do Jacuípe included 446 persons; 45.7% were CHIKV-positive, 41.2% reported symptoms, and 75.0% contracted the chronic form. Our data confirm intense CHIKV transmission during the continuing epidemic. Chronic pain developed in a high proportion of patients. We recommend training health professionals in management of chronic pain, which will improve the quality of life of chikungunya-affected persons.
Keywords: Brazil; CHIKV; attack rate; chikungunya virus; incidence; mosquito; seroprevalence; survey; vector-borne infections; viruses.
Figures
Comment in
-
Seroprevalence of Chikungunya Virus after Its Emergence in Brazil.Emerg Infect Dis. 2018 Sep;24(9):1773. doi: 10.3201/eid2409.180724. Emerg Infect Dis. 2018. PMID: 30124419 Free PMC article. No abstract available.
References
-
- Pan American Health Organization. New cases of chikungunya in the Americas 2013–2017, per year and country [cited 2018 Feb 15]. http://ais.paho.org/phip/viz/ed_chikungunya_amro.asp
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
